| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 41.8255 | 12 |
| GSM780708 | Untreated after 4 days (C2_1) | 42.7983 | 17 |
| GSM780709 | Untreated after 4 days (C3_1) | 42.3952 | 15 |
| GSM780719 | Untreated after 4 days (C1_2) | 42.2781 | 14 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.5974 | 20 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.5723 | 35 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 43.0327 | 18 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 41.5276 | 11 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.0403 | 27 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 41.4146 | 11 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.0896 | 32 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 44.7292 | 26 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 39.6651 | 6 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 38.52 | 3 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.6298 | 16 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 38.917 | 4 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 40.5294 | 8 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.6314 | 30 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 41.1405 | 10 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 40.7253 | 9 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.5079 | 25 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 42.0716 | 13 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.2922 | 24 |